Corteva (NYSE:CTVA) Hits New 1-Year High – Time to Buy?

Corteva, Inc. (NYSE:CTVA) shares hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $85.85 and last traded at $85.5690, with a volume of 404426 shares changing hands. The stock had previously closed at $84.69.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the company. BNP Paribas Exane raised their price objective on Corteva from $74.00 to $77.00 in a research note on Wednesday, May 6th. Oppenheimer boosted their target price on Corteva from $86.00 to $89.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 22nd. Weiss Ratings raised shares of Corteva from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, May 7th. Royal Bank Of Canada raised their price target on shares of Corteva from $95.00 to $97.00 and gave the company an “outperform” rating in a research note on Thursday, May 7th. Finally, Morgan Stanley lifted their price target on shares of Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a report on Thursday, May 28th. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat.com, Corteva has an average rating of “Moderate Buy” and an average target price of $88.90.

Corteva Price Performance

The business has a 50-day moving average of $79.67 and a two-hundred day moving average of $76.80. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07. The firm has a market cap of $57.27 billion, a P/E ratio of 50.37, a price-to-earnings-growth ratio of 2.56 and a beta of 0.56.

Corteva (NYSE:CTVA) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, beating analysts’ consensus estimates of $1.18 by $0.32. The firm had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The business’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same period last year, the firm posted $1.13 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, sell-side analysts anticipate that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Monday, June 1st were given a dividend of $0.18 per share. The ex-dividend date was Monday, June 1st. This represents a $0.72 annualized dividend and a yield of 0.8%. Corteva’s dividend payout ratio (DPR) is currently 42.35%.

Hedge Funds Weigh In On Corteva

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Drummond Knight Asset Management Pty Ltd bought a new position in shares of Corteva during the fourth quarter worth about $25,713,000. Avior Wealth Management LLC boosted its holdings in Corteva by 464.7% in the fourth quarter. Avior Wealth Management LLC now owns 32,901 shares of the company’s stock valued at $2,205,000 after acquiring an additional 27,075 shares during the last quarter. Arbejdsmarkedets Tillaegspension bought a new stake in Corteva in the fourth quarter valued at approximately $23,679,000. Squarepoint Ops LLC increased its position in Corteva by 423.6% during the 3rd quarter. Squarepoint Ops LLC now owns 1,738,139 shares of the company’s stock valued at $117,550,000 after purchasing an additional 1,406,199 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. raised its holdings in Corteva by 23.5% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 110,075 shares of the company’s stock worth $7,378,000 after purchasing an additional 20,957 shares during the last quarter. 81.54% of the stock is currently owned by institutional investors and hedge funds.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.